EN PL

EMA: Reflection paper on pharmacovigilance communication concerning veterinary medicinal products - Draft

21.02.2013
The experience gained by regulatory authorities has demonstrated the need and the benefits of streamlining and coordinating the communication process effectively within the European Union (EU) regulatory network which is of particular relevance when it refers to pharmacovigilance communication. This document will provide an overview of different types of communication tools used by national competent authorities, the European Medicines Agency and marketing-authorisation holders with specific focus on direct veterinary medicine communication.